[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2018 Global Recombinant Factor VIII Industry Report - History, Present and Future

December 2018 | 139 pages | ID: 28BF0A2350APEN
Prof Research

US$ 3,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global market size of Recombinant Factor VIII is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX million by the end of 2023 with a CAGR of XX% from 2018 to 2023.

There are 3 key segments covered in this report: geography segment, end use/application segment and competitor segment.

For geography segment, regional supply, application-wise and type-wise demand, major players, price is presented from 2013 to 2023. This report coverss following regions:
  • North America
  • South America
  • Asia & Pacific
  • Europe
  • MEA (Middle East and Africa)
The key countries in each region are taken into consideration as well, such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For end use/application segment, this report focuses on the status and outlook for key applications. End users also can be listed.

For competitor segment, the report includes global key players of Recombinant Factor VIII as well as some small players. The compnaies include:

Shire (Baxter), Bayer, CSL, Pfizer, Biogen, Octapharma, NovoNordisk et al.

The information for each competitor includes:
  • Company Profile
  • Main Business Information
  • SWOT Analysis
  • Sales, Revenue, Price and Gross Margin
  • Market Share
We also can offer customized report to fulfill special requirements of our clients.
CHAPTER 1 EXECUTIVE SUMMARY

CHAPTER 2 ABBREVIATION AND ACRONYMS

CHAPTER 3 PREFACE

3.1 Research Scope
3.2 Research Methodology
  3.2.1 Data Collection
  3.2.2 Data Analysis
  3.2.3 Data Validation
3.3 Research Sources
  3.3.1 Primary Sources
  3.3.2 Secondary Sources
  3.3.3 Assumptions

CHAPTER 4 MARKET LANDSCAPE

4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users

CHAPTER 5 MARKET TREND ANALYSIS

5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats

CHAPTER 6 INDUSTRY CHAIN ANALYSIS

6.1 Upstream/Suppliers Analysis
6.2 Recombinant Factor VIII Analysis
  6.2.1 Technology Analysis
  6.2.2 Cost Analysis
  6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users

CHAPTER 7 LATEST MARKET DYNAMICS

7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics

CHAPTER 8 TRADING ANALYSIS

8.1 Export of Recombinant Factor VIII by Region
8.2 Import of Recombinant Factor VIII by Region
8.3 Balance of Trade

CHAPTER 9 HISTORICAL AND CURRENT RECOMBINANT FACTOR VIII MARKET IN NORTH AMERICA (2013-2018)

9.1 Recombinant Factor VIII Supply
9.2 Recombinant Factor VIII Demand by End Use
9.3 Competition by Players/Suppliers
9.4 Type Segmentation and Price
9.5 Key Countries Analysis

CHAPTER 10 HISTORICAL AND CURRENT RECOMBINANT FACTOR VIII MARKET IN SOUTH AMERICA (2013-2018)

10.1 Recombinant Factor VIII Supply
10.2 Recombinant Factor VIII Demand by End Use
10.3 Competition by Players/Suppliers
10.4 Type Segmentation and Price
10.5 Key Countries Analysis

CHAPTER 11 HISTORICAL AND CURRENT RECOMBINANT FACTOR VIII MARKET IN ASIA & PACIFIC (2013-2018)

11.1 Recombinant Factor VIII Supply
11.2 Recombinant Factor VIII Demand by End Use
11.3 Competition by Players/Suppliers
11.4 Type Segmentation and Price
11.5 Key Countries Analysis

CHAPTER 12 HISTORICAL AND CURRENT RECOMBINANT FACTOR VIII MARKET IN EUROPE (2013-2018)

12.1 Recombinant Factor VIII Supply
12.2 Recombinant Factor VIII Demand by End Use
12.3 Competition by Players/Suppliers
12.4 Type Segmentation and Price
12.5 Key Countries Analysis

CHAPTER 13 HISTORICAL AND CURRENT RECOMBINANT FACTOR VIII MARKET IN MEA (2013-2018)

13.1 Recombinant Factor VIII Supply
13.2 Recombinant Factor VIII Demand by End Use
13.3 Competition by Players/Suppliers
13.4 Type Segmentation and Price
13.5 Key Countries Analysis

CHAPTER 14 SUMMARY FOR GLOBAL RECOMBINANT FACTOR VIII MARKET (2013-2018)

14.1 Recombinant Factor VIII Supply
14.2 Recombinant Factor VIII Demand by End Use
14.3 Competition by Players/Suppliers
14.4 Type Segmentation and Price

CHAPTER 15 GLOBAL RECOMBINANT FACTOR VIII MARKET FORECAST (2019-2023)

15.1 Recombinant Factor VIII Supply Forecast
15.2 Recombinant Factor VIII Demand Forecast
15.3 Competition by Players/Suppliers
15.4 Type Segmentation and Price Forecast

CHAPTER 16 COMPANY PROFILE(SHIRE (BAXTER), BAYER, CSL, PFIZER, BIOGEN, OCTAPHARMA, NOVONORDISK ET AL.)

16.1 Company A
  16.1.1 Company Profile
  16.1.2 Main Business and Recombinant Factor VIII Information
  16.1.3 SWOT Analysis of Company A
  16.1.4 Company A Recombinant Factor VIII Sales, Revenue, Price and Gross Margin (2013-2018)
16.2 Company B
  16.2.1 Company Profile
  16.2.2 Main Business and Recombinant Factor VIII Information
  16.2.3 SWOT Analysis of Company B
  16.2.4 Company B Recombinant Factor VIII Sales, Revenue, Price and Gross Margin (2013-2018)
16.3 Company C
  16.3.1 Company Profile
  16.3.2 Main Business and Recombinant Factor VIII Information
  16.3.3 SWOT Analysis of Company C
  16.3.4 Company C Recombinant Factor VIII Sales, Revenue, Price and Gross Margin (2013-2018)
16.4 Company D
  16.4.1 Company Profile
  16.4.2 Main Business and Recombinant Factor VIII Information
  16.4.3 SWOT Analysis of Company D
  16.4.4 Company D Recombinant Factor VIII Sales, Revenue, Price and Gross Margin (2013-2018)
16.5 Company E
  16.5.1 Company Profile
  16.5.2 Main Business and Recombinant Factor VIII Information
  16.5.3 SWOT Analysis of Company E
  16.5.4 Company E Recombinant Factor VIII Sales, Revenue, Price and Gross Margin (2013-2018)
16.6 Company F
  16.6.1 Company Profile
  16.6.2 Main Business and Recombinant Factor VIII Information
  16.6.3 SWOT Analysis of Company F
  16.6.4 Company F Recombinant Factor VIII Sales, Revenue, Price and Gross Margin (2013-2018)
16.7 Company G
  16.7.1 Company Profile
  16.7.2 Main Business and Recombinant Factor VIII Information
  16.7.3 SWOT Analysis of Company G
  16.7.4 Company G Recombinant Factor VIII Sales, Revenue, Price and Gross Margin (2013-2018)

TABLES AND FIGURES

Table Abbreviation and Acronyms List
Table Research Scope of Recombinant Factor VIII Report
Table Primary Sources of Recombinant Factor VIII Report
Table Secondary Sources of Recombinant Factor VIII Report
Table Major Assumptions of Recombinant Factor VIII Report
Figure Recombinant Factor VIII Picture
Table Recombinant Factor VIII Classification
Table Recombinant Factor VIII Applications List
Table Drivers of Recombinant Factor VIII Market
Table Restraints of Recombinant Factor VIII Market
Table Opportunities of Recombinant Factor VIII Market
Table Threats of Recombinant Factor VIII Market
Table Key Raw Material of Recombinant Factor VIII and Its Suppliers
Table Key Technologies of Recombinant Factor VIII
Table Cost Structure of Recombinant Factor VIII
Table Market Channel of Recombinant Factor VIII
Table Recombinant Factor VIII Application and Key End Users List
Table Latest News of Recombinant Factor VIII Industry
Table Recently Merger and Acquisition List of Recombinant Factor VIII Industry
Table Recently Planned/Future Project List of Recombinant Factor VIII Industry
Table Policy Dynamics Update of Recombinant Factor VIII Industry
Table 2013-2023 Export of Recombinant Factor VIII by Region
Table 2013-2023 Import of Recombinant Factor VIII by Region
Table 2013-2023 Balance of Trade of Recombinant Factor VIII
Figure 2013 2018 and 2023 Global Trade Map of Recombinant Factor VIII
Table 2013-2018 North America Supply of Recombinant Factor VIII
Figure 2013-2018 North America Recombinant Factor VIII Supply and GAGR
Table 2013-2018 North America Recombinant Factor VIII Downstream Demand List
Figure 2013-2018 North America Recombinant Factor VIII Downstream Demand and CAGR
Figure 2013 Major Players Market Share in North America
Figure 2018 Major Players Market Share in North America
Table 2013-2018 North America Recombinant Factor VIII Demand by Type
Figure 2013-2018 North America Recombinant Factor VIII Price
Table 2013-2018 Key Countries Supply of Recombinant Factor VIII in North America
Table 2013-2018 Key Countries Market Share of Supply in North America
Table 2013-2018 Key Countries Demand of Recombinant Factor VIII in North America
Table 2013-2018 Key Countries Market Share of Demand in North America
Table 2013-2018 South America Supply of Recombinant Factor VIII
Figure 2013-2018 South America Recombinant Factor VIII Supply and GAGR
Table 2013-2018 South America Recombinant Factor VIII Downstream Demand List
Figure 2013-2018 South America Recombinant Factor VIII Downstream Demand and CAGR
Figure 2013 Major Players Market Share in South America
Figure 2018 Major Players Market Share in South America
Table 2013-2018 South America Recombinant Factor VIII Demand by Type
Figure 2013-2018 South America Recombinant Factor VIII Price
Table 2013-2018 Key Countries Supply of Recombinant Factor VIII in South America
Table 2013-2018 Key Countries Market Share of Supply in South America
Table 2013-2018 Key Countries Demand of Recombinant Factor VIII in South America
Table 2013-2018 Key Countries Market Share of Demand in South America
Table 2013-2018 Asia & Pacific Supply of Recombinant Factor VIII
Figure 2013-2018 Asia & Pacific Recombinant Factor VIII Supply and GAGR
Table 2013-2018 Asia & Pacific Recombinant Factor VIII Downstream Demand List
Figure 2013-2018 Asia & Pacific Recombinant Factor VIII Downstream Demand and CAGR
Figure 2013 Major Players Market Share in Asia & Pacific
Figure 2018 Major Players Market Share in Asia & Pacific
Table 2013-2018 Asia & Pacific Recombinant Factor VIII Demand by Type
Figure 2013-2018 Asia & Pacific Recombinant Factor VIII Price
Table 2013-2018 Key Countries Supply of Recombinant Factor VIII in Asia & Pacific
Table 2013-2018 Key Countries Market Share of Supply in Asia & Pacific
Table 2013-2018 Key Countries Demand of Recombinant Factor VIII in Asia & Pacific
Table 2013-2018 Key Countries Market Share of Demand in Asia & Pacific
Table 2013-2018 Europe Supply of Recombinant Factor VIII
Figure 2013-2018 Europe Recombinant Factor VIII Supply and GAGR
Table 2013-2018 Europe Recombinant Factor VIII Downstream Demand List
Figure 2013-2018 Europe Recombinant Factor VIII Downstream Demand and CAGR
Figure 2013 Major Players Market Share in Europe
Figure 2018 Major Players Market Share in Europe
Table 2013-2018 Europe Recombinant Factor VIII Demand by Type
Figure 2013-2018 Europe Recombinant Factor VIII Price
Table 2013-2018 Key Countries Supply of Recombinant Factor VIII in Europe
Table 2013-2018 Key Countries Market Share of Supply in Europe
Table 2013-2018 Key Countries Demand of Recombinant Factor VIII in Europe
Table 2013-2018 Key Countries Market Share of Demand in Europe
Table 2013-2018 MEA Supply of Recombinant Factor VIII
Figure 2013-2018 MEA Recombinant Factor VIII Supply and GAGR
Table 2013-2018 MEA Recombinant Factor VIII Downstream Demand List
Figure 2013-2018 MEA Recombinant Factor VIII Downstream Demand and CAGR
Figure 2013 Major Players Market Share in MEA
Figure 2018 Major Players Market Share in MEA
Table 2013-2018 MEA Recombinant Factor VIII Demand by Type
Figure 2013-2018 MEA Recombinant Factor VIII Price
Table 2013-2018 Key Countries Supply of Recombinant Factor VIII in MEA
Table 2013-2018 Key Countries Market Share of Supply in MEA
Table 2013-2018 Key Countries Demand of Recombinant Factor VIII in MEA
Table 2013-2018 Key Countries Market Share of Demand in MEA
Table 2013-2018 Global Supply of Recombinant Factor VIII by Region
Figure 2013-2018 Global Supply and CAGR of Recombinant Factor VIII by Region
Table 2013-2018 Global Recombinant Factor VIII Downstream Demand List by Region
Figure 2013-2018 Global Recombinant Factor VIII Downstream Demand and CAGR by Region
Figure 2013 Global Major Players Market Share
Figure 2018 Global Major Players Market Share
Table 2013-2018 Global Recombinant Factor VIII Type-wise Demand by Region
Figure 2013-2018 Global Recombinant Factor VIII Price
Table Main Business and Recombinant Factor VIII Information of Company A
Table SWOT Analysis of Company A
Table 2013-2018 Company A Recombinant Factor VIII Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company A Recombinant Factor VIII Sales Revenue and Growth Rate
Figure 2013-2018 Company A Recombinant Factor VIII Market Share
Table Main Business and Recombinant Factor VIII Information of Company B
Table SWOT Analysis of Company B
Table 2013-2018 Company B Recombinant Factor VIII Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company B Recombinant Factor VIII Sales Revenue and Growth Rate
Figure 2013-2018 Company B Recombinant Factor VIII Market Share
Table Main Business and Recombinant Factor VIII Information of Company C
Table SWOT Analysis of Company C
Table 2013-2018 Company C Recombinant Factor VIII Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company C Recombinant Factor VIII Sales Revenue and Growth Rate
Figure 2013-2018 Company C Recombinant Factor VIII Market Share
Table Main Business and Recombinant Factor VIII Information of Company D
Table SWOT Analysis of Company D
Table 2013-2018 Company D Recombinant Factor VIII Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company D Recombinant Factor VIII Sales Revenue and Growth Rate
Figure 2013-2018 Company D Recombinant Factor VIII Market Share
Table Main Business and Recombinant Factor VIII Information of Company E
Table SWOT Analysis of Company E
Table 2013-2018 Company E Recombinant Factor VIII Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company E Recombinant Factor VIII Sales Revenue and Growth Rate
Figure 2013-2018 Company E Recombinant Factor VIII Market Share
Table Main Business and Recombinant Factor VIII Information of Company F
Table SWOT Analysis of Company F
Table 2013-2018 Company F Recombinant Factor VIII Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company F Recombinant Factor VIII Sales Revenue and Growth Rate
Figure 2013-2018 Company F Recombinant Factor VIII Market Share
Table Main Business and Recombinant Factor VIII Information of Company G
Table SWOT Analysis of Company G
Table 2013-2018 Company G Recombinant Factor VIII Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company G Recombinant Factor VIII Sales Revenue and Growth Rate
Figure 2013-2018 Company G Recombinant Factor VIII Market Share


More Publications